HUT77075A - Hatóanyagok és alkalmazásuk - Google Patents

Hatóanyagok és alkalmazásuk

Info

Publication number
HUT77075A
HUT77075A HU9702199A HU9702199A HUT77075A HU T77075 A HUT77075 A HU T77075A HU 9702199 A HU9702199 A HU 9702199A HU 9702199 A HU9702199 A HU 9702199A HU T77075 A HUT77075 A HU T77075A
Authority
HU
Hungary
Prior art keywords
active ingredients
ingredients
active
Prior art date
Application number
HU9702199A
Other languages
English (en)
Other versions
HU221089B1 (en
Inventor
Amanda Elizabeth Innes Proudfoot
Timothy Nigel Carl Wells
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9424835.8A external-priority patent/GB9424835D0/en
Priority claimed from GBGB9512319.6A external-priority patent/GB9512319D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of HUT77075A publication Critical patent/HUT77075A/hu
Publication of HU221089B1 publication Critical patent/HU221089B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HU9702199A 1994-12-08 1995-12-07 Rantes peptide derivates with antagonistic effect and uses thereof HU221089B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9424835.8A GB9424835D0 (en) 1994-12-08 1994-12-08 Substances and their uses
GBGB9512319.6A GB9512319D0 (en) 1995-06-16 1995-06-16 Substances and their uses
PCT/GB1995/002861 WO1996017935A2 (en) 1994-12-08 1995-12-07 Rantes peptide and fragments and compositions comprising it for treatment of inflammation

Publications (2)

Publication Number Publication Date
HUT77075A true HUT77075A (hu) 1998-03-02
HU221089B1 HU221089B1 (en) 2002-08-28

Family

ID=26306133

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9702199A HU221089B1 (en) 1994-12-08 1995-12-07 Rantes peptide derivates with antagonistic effect and uses thereof

Country Status (15)

Country Link
US (2) US6159711A (hu)
EP (1) EP0796330A1 (hu)
JP (1) JPH10510151A (hu)
CN (1) CN1087346C (hu)
AU (1) AU688641B2 (hu)
BR (1) BR9509890A (hu)
CA (1) CA2207036A1 (hu)
CZ (1) CZ290850B6 (hu)
FI (1) FI972433A0 (hu)
HU (1) HU221089B1 (hu)
MX (1) MX9703889A (hu)
NO (1) NO972620L (hu)
NZ (1) NZ296570A (hu)
PL (1) PL182786B1 (hu)
WO (1) WO1996017935A2 (hu)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10510151A (ja) * 1994-12-08 1998-10-06 グラクソ、グループ、リミテッド Ｒａｎｔｅｓペプチドおよびフラグメント並びにそれを含んでなる炎症治療用組成物
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
AU4561497A (en) * 1996-09-25 1998-04-17 British Biotech Pharmaceuticals Limited Human rantes mutants incapable of aggregate formation
US6100387A (en) * 1997-02-28 2000-08-08 Genetics Institute, Inc. Chimeric polypeptides containing chemokine domains
US6852508B1 (en) 1997-02-28 2005-02-08 Genetics Institute, Llc Chemokine with amino-terminal modifications
IT1291353B1 (it) * 1997-05-12 1999-01-07 San Raffaele Centro Fond Peptidi con attivita' antivirale
US6168784B1 (en) 1997-09-03 2001-01-02 Gryphon Sciences N-terminal modifications of RANTES and methods of use
EP0906954A1 (en) * 1997-09-29 1999-04-07 Applied Research Systems ARS Holding N.V. Amino-terminal truncated c-c chemokines as chemokine antagonist
MXPA00003885A (es) * 1997-10-22 2004-04-23 Inst Genetics Llc Quimiocinas con modificiaciones de la terminacion amino.
DE69832197T2 (de) * 1997-12-23 2006-05-24 Fondazione Centro San Raffaele Del Monte Tabor Rantes-mutanten und therapeutische anwendungen davon
US6121023A (en) * 1998-01-22 2000-09-19 Akzo Nobel N.V. Isothermal transcription based assay for the detection and quantification of the chemokine rantes
EP1000626A1 (en) 1998-09-18 2000-05-17 Applied Research Systems ARS Holding N.V. Chemokine receptor antagonist and cyclosporin in combined therapy
IT1303736B1 (it) * 1998-11-11 2001-02-23 San Raffaele Centro Fond Peptidi derivati da rantes con attivita' anti-hiv.
WO2000056879A1 (en) * 1999-03-22 2000-09-28 Universität Zürich TRANSFORMING GROWTH FACTOR (TFG) β SUPERFAMILY ANTAGONISTS
WO2002020033A1 (en) 2000-09-08 2002-03-14 Gryphon Therapeutics, Inc. Polymer-modified synthetic proteins
US7998681B2 (en) * 2000-10-06 2011-08-16 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Diagnosis and therapy of antibody-mediated inflammatory auto-immune disorders
US8153121B2 (en) * 2000-10-06 2012-04-10 Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders
EP1506400A2 (en) * 2001-10-30 2005-02-16 President And Fellows Of Harvard College Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor
AU2002358144B2 (en) * 2001-12-17 2008-10-02 Laboratoires Serono Sa Chemokine mutants acting as chemokine antagonists
US20040191215A1 (en) * 2003-03-25 2004-09-30 Michael Froix Compositions for induction of a therapeutic response
US7390788B2 (en) * 2005-06-23 2008-06-24 Pert Candace B Peptide pharmaceutical compositions
WO2008015199A1 (en) * 2006-07-31 2008-02-07 Laboratoires Serono S.A. Chemokine antagonists
MX2010001307A (es) 2007-08-02 2010-07-30 Novimmune Sa Anticuerpos anti-proteína regulada con la activación, expresada y secretada por los linfocitos t normales y metodos de uso de los mismos.
US9034313B2 (en) 2010-02-08 2015-05-19 The Trustees Of The University Of Pennsylvania Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same
WO2013024022A1 (en) 2011-08-12 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for treatment of pulmonary hypertension
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
US20240409596A1 (en) 2021-10-06 2024-12-12 Virothera Limited Novel immune regulator

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10510151A (ja) * 1994-12-08 1998-10-06 グラクソ、グループ、リミテッド Ｒａｎｔｅｓペプチドおよびフラグメント並びにそれを含んでなる炎症治療用組成物

Also Published As

Publication number Publication date
MX9703889A (es) 1997-08-30
NO972620L (no) 1997-08-06
NO972620D0 (no) 1997-06-06
JPH10510151A (ja) 1998-10-06
FI972433L (fi) 1997-06-06
AU4120896A (en) 1996-06-26
PL320565A1 (en) 1997-10-13
FI972433A7 (fi) 1997-06-06
CZ290850B6 (cs) 2002-10-16
BR9509890A (pt) 1997-12-30
CN1087346C (zh) 2002-07-10
CN1168697A (zh) 1997-12-24
PL182786B1 (pl) 2002-02-28
US6159711A (en) 2000-12-12
AU688641B2 (en) 1998-03-12
US6555105B1 (en) 2003-04-29
EP0796330A1 (en) 1997-09-24
WO1996017935A3 (en) 1996-08-22
HU221089B1 (en) 2002-08-28
CZ171997A3 (en) 1997-11-12
NZ296570A (en) 1998-11-25
CA2207036A1 (en) 1996-06-13
FI972433A0 (fi) 1997-06-06
WO1996017935A2 (en) 1996-06-13

Similar Documents

Publication Publication Date Title
HUT77075A (hu) Hatóanyagok és alkalmazásuk
HUT77359A (hu) Aranyérellenes készítmények és alkalmazásuk
TR199501137A2 (tr) Terapötik olarak aktif bilesenler
NL300295I2 (nl) 3,3-diarylpropylaminen, de toepassing en bereidinghiervan
NO933434D0 (no) Piperidinderivater, deres fremstilling og anvendelse
FI952179A7 (fi) Uusia 3,3-difenyylipropyyliamiineja, niiden käyttö ja valmistus
IL113844A (en) N-(alpha-ETHYLBENZYL)-3-HYDROXY-2-PHENYLQUINOLINE-4-CARBOXAMIDE AND ITS USE IN THE PREPARATION OF MEDICAMENTS
FI955235A7 (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
EP0790826A4 (en) DIHYDROPYRIMIDINES AND THEIR USES
FI964311L (fi) Bifunktionaalinen proteiini, valmistus ja käyttö
BR9504060A (pt) Composto e formulação farmacêutica
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
FR2744442B1 (fr) Preparation du 1,1,1,3,3-pentachlorobutane et du 1,1,1,3,3,-pentafluorobutane
DE69629751D1 (de) Wässrige Reinigungs- und Pflegezusammensetzung
FI951817A7 (fi) Orgonaluminoksituote, sen valmistus ja käyttö
DE69830119D1 (de) Teigzusammensetzung und derer Herstellung
FI951060L (fi) Formulaatioita ja hoitomenetelmiä
FI970997L (fi) Bentsosykloalkeeniyhdisteet, niiden valmistus ja käyttö
BR9509688A (pt) Composto e composição farmacêutica
FI930716A7 (fi) Uusia aryylikarbonyyliaminoalkyylidihydro-oksopyridiinejä, niiden valmistus ja käyttö
DK60893D0 (da) Piperidinderivater, deres fremstilling og anvendelse
NO933435D0 (no) Piperidinderivater, deres fremstilling og anvendelse
TR28936A (tr) 2-arilpirimidinler ve bunlarin herbisit olarak kullanimi
ATE228575T1 (de) Wirkstoffkombinationen
FI972965A7 (fi) Uusia peptidejä, niiden valmistus ja käyttö

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee